{"id":15124,"date":"2025-10-09T14:59:40","date_gmt":"2025-10-09T12:59:40","guid":{"rendered":"https:\/\/semmelweis.hu\/pharmacology\/?page_id=15124"},"modified":"2026-02-09T13:16:33","modified_gmt":"2026-02-09T12:16:33","slug":"grants","status":"publish","type":"page","link":"https:\/\/semmelweis.hu\/pharmacology\/en\/research\/grants\/","title":{"rendered":"Grants"},"content":{"rendered":"
Grants<\/strong><\/span><\/div>\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Grant<\/th>Principal Investigator<\/th>Funding<\/th>Project ID<\/th>Project Title<\/th>Start of the Funding Period<\/th>End of the Funding Period<\/th>Semmelweis University Partners<\/th>External Partners<\/th>\n<\/tr>\n<\/thead>\n
National Cardiovascular Laboratory<\/td>B\u00e9la Merkely, MD, PhD<\/td>5.670.176.720 HUF<\/td>RRF-2.3.1-21-2022-00003<\/td>National Cardiovascular Laboratory<\/td>1 April 2022<\/td>28 February 2026<\/td>V\u00e1rosmajor Heart and Vascular Surgery Clinic (Consortium Lead), Institute of Public Health, Institute of Genetics, Cell and Immunobiology, Department of Internal Medicine and Oncology<\/td>Univesity of Szeged, Pharmahungary 2000 Kft., Intersynk Kft., 3D Histech Kft.<\/td>\n<\/tr>\n
Establishing and developing competence centres <\/td>P\u00e9ter Ferdinandy, MD, PhD, MBA<\/td>3.886.027.141 HUF<\/td>2022-1.1.1-KK-2022-00005 <\/td>The Future Health Competence Centre at Semmelweis University<\/td>1 April 2023<\/td>31 March 2028<\/td><\/td>Femtonics Kft., MEDRES Kft., Oncompass Medicine Hungary Kft., Richter Gedeon Nyrt. <\/td>\n<\/tr>\n
HU-rizon Programme<\/td>P\u00e9ter Ferdinandy, MD, PhD, MBA<\/td>400.000.000 HUF<\/td>2024-1.2.3-HU-RIZONT-2024-00026<\/td>Development of an artificial intelligence\u2013based drug discovery platform: application of microRNA therapy in cardiometabolic and oncological diseases<\/td>1 March 2025<\/td>29 February 2028<\/td><\/td><\/td>\n<\/tr>\n
Semmelweis University Internal Momentum Programme 2024<\/td>P\u00e9ter Ferdinandy, MD, PhD, MBA<\/td>50.000.000 HUF<\/td>SE11594386<\/td>Development of microRNA therapies for cardiometabolic and oncological diseases<\/td>15 July 2024<\/td>14 July 2025<\/td><\/td><\/td>\n<\/tr>\n
Semmelweis University Internal Momentum Programme 2025<\/td>P\u00e9ter Ferdinandy, MD, PhD, MBA<\/td>50.000.000 HUF<\/td>SE11594387<\/td>Development of microRNA therapies for cardiometabolic and oncological diseases<\/td>15 July 2025<\/td>14 July 2026<\/td><\/td><\/td>\n<\/tr>\n
Thematic Excellence Programme 2021 \u2013 Health Subprogramme<\/td>P\u00e9ter Ferdinandy, MD, PhD, MBA<\/td>332.500.000 HUF<\/td>TKP2021-EGA-23<\/td>Translational research and innovation in the diagnosis and therapy of ischemic heart disease and its comorbidities<\/td>1 August 2021<\/td>December 31 2025<\/td>V\u00e1rosmajor Heart and Vascular Surgery Clinic, Institute of Genetics, Cell and Immunobiology, Department of Oral Biology, Center for Translational Medicine, Institute of Biophysics and Radiation Biology<\/td><\/td>\n<\/tr>\n
Support for Bilateral Scientific and Technological Cooperation (2024-1.2.5-T\u00c9T)<\/td>Anik\u00f3 G\u00f6rbe, MD, PhD<\/td>3.000.000 HUF<\/td>2024-1.2.5-T\u00c9T-2024-00059<\/td>Development of novel microRNA-based therapies for the protection of cardiac function<\/td>1 July 2025<\/td>30 June 2027<\/td><\/td>Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia<\/td>\n<\/tr>\n
K_21 OTKA<\/td>Anik\u00f3 G\u00f6rbe, MD, PhD<\/td>45.983.000 HUF<\/td>K 139237<\/td>Investigation of hidden cardiotoxicity and cardioprotection using translational cell culture models<\/td>1 September 2021<\/td>30 June 2026<\/td><\/td><\/td>\n<\/tr>\n
Momentum Programme<\/td>Zolt\u00e1n Varga, MD, PhD<\/td>180.002.000 HUF<\/td>LP-2021-14<\/td>Investigation of the molecular mechanisms of cardiological and onco-cardiological diseases, as well as their therapeutic and diagnostic applications<\/td>01 December 2021<\/td>30 November 2026<\/td><\/td><\/td>\n<\/tr>\n
OTKA FK<\/td>Zolt\u00e1n Varga, MD, PhD<\/td>39.996.000 HUF<\/td>OTKA FK 134751<\/td>Novel inflammatory mechanisms in the development of heart failure<\/td>01 December 2020<\/td>30 November 2025<\/td><\/td><\/td>\n<\/tr>\n
K_21 OTKA<\/td>Zolt\u00e1n Giricz, PharmD, PhD<\/td>46.960.000 HUF<\/td>K 139105<\/td>Impact of metabolic diseases on extracellular vesicle\u2013based signaling in the cardiovascular system<\/td>1 September 2021<\/td>31 July 2026<\/td><\/td><\/td>\n<\/tr>\n
Support for International Professional and Scientific Cooperation (2024-1.2.9-NETWORKING)<\/td>Zolt\u00e1n Giricz, PharmD, PhD<\/td>3.000.000 HUF<\/td>2024-1.2.9-NETWORKING-2024-00016<\/td>Participation in the leadership of the European Society of Cardiology Working Group on Cellular Biology with the aim of developing position papers<\/td>1 August 2025<\/td>31 July 2026<\/td><\/td><\/td>\n<\/tr>\n
National Research Excellence Programme 2025 - ADVANCED <\/td>Zolt\u00e1n Giricz, PharmD, PhD<\/td>147.000.000 HUF<\/td> ADVANCED 15291<\/td>Investigation of the therapeutic potential of stem cell\u2013derived extracellular vesicles in cancer therapy\u2013induced cardiac injury<\/td>1 January 2026<\/td>31 December 2029<\/td><\/td><\/td>\n<\/tr>\n
National Research Excellence Programme 2025 - STARTING <\/td>Andr\u00e1s Makkos, MD, PhD<\/td>97.200.000 HUF<\/td>STARTING_152265<\/td>Preclinical development of cardioprotective microRNA molecules (ProtectomiRs)<\/td>1 January 2026<\/td>31 December 2029<\/td><\/td><\/td>\n<\/tr>\n
National Research Excellence Program 2025 - STARTING <\/td>Zs\u00f3fia Guly\u00e1s-On\u00f3di, MD, PhD<\/td>125.000.000 HUF<\/td>STARTING 152247<\/td>Investigation of immuno-inflammatory processes and their pharmacological relevance in heart diseases and their comorbidities<\/td>1January 2026<\/td>31 December 2029<\/td><\/td><\/td>\n<\/tr>\n
Mecenatura 2024<\/td>Zs\u00f3fia Guly\u00e1s-On\u00f3di, MD, PhD<\/td>1.250.000 HUF<\/td>148972<\/td>Investigation of organ-level alterations in the inflammatory environment in a rat model of heart failure<\/td>9 October 2024<\/td>8 October 2025<\/td><\/td><\/td>\n<\/tr>\n
Bolyai J\u00e1nos Scholarship 2023<\/td>G\u00e1bor M\u00f3rotz, PhD<\/td>9.000.000 HUF<\/td>BO\/00277\/23\/5<\/td>Adrenal steroid hormone synthesis and endoplasmic reticulum (ER)\u2013mitochondrial signaling in post-infarction heart failure<\/td>1 September 2023<\/td>31 August 2026<\/td><\/td><\/td>\n<\/tr>\n
OTKA FK<\/td>G\u00e1bor M\u00f3rotz, PhD<\/td>44.000.000 HUF<\/td>FK_146163<\/td>Endothelial cells and ER\u2013mitochondrial signaling in myocardial infarction\u2013associated microvascular obstruction<\/td>1 January 2024<\/td>31 December 2027<\/td><\/td><\/td>\n<\/tr>\n
Richter Talentum Excellence PhD Scholarship<\/td>Rich\u00e1rd R\u00e1cz<\/td>6.400.000 HUF<\/td><\/td>Richter Talentum Excellence PhD Scholarship<\/td>1 September 2024<\/td>31 August 2026<\/td><\/td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n

 <\/p>\n

\n

Research projects funded by grants<\/span><\/strong><\/p>\n<\/div>\n